The main findings were that TTX administration reduced both the pain responses and the referred mechanical hyperalgesia in colonic and cystitis pain models, and that the TTX-sensitive channel Nav1.7 was not involved in those effects. This evidence concerns the gene SCN9A and chronic cystitis.